Designing nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivo.

Designing nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivo.

Pancreatic cancer is the fourth leading cause of cancer related deaths in America. Monoclonal antibodies are a viable treatment option for inhibiting cancer growth. Tumor specific drug delivery could be achieved utilizing these monoclonal antibodies as targeting agents. This type of designer therape...

Full description

Bibliographic Details
Main Authors: Jameel Ahmad Khan, Rachel A Kudgus, Annamaria Szabolcs, Shamit Dutta, Enfeng Wang, Sheng Cao, Geoffry L Curran, Vijay Shah, Steven Curley, Debabrata Mukhopadhyay, J David Robertson, Resham Bhattacharya, Priyabrata Mukherjee
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3124468?pdf=render

Internet

http://europepmc.org/articles/PMC3124468?pdf=render

Similar Items